Page last updated: 2024-11-01

norfloxacin and Cerebral Pseudosclerosis

norfloxacin has been researched along with Cerebral Pseudosclerosis in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research Excerpts

ExcerptRelevanceReference
"Norfloxacin method is a simple, inexpensive and automatable kinetic assay."1.34A kinetic method amenable to automation for ceruloplasmin estimation with inexpensive and stable reagents. ( Ambade, V; Somani, BL, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Somani, BL1
Ambade, V1

Other Studies

1 other study available for norfloxacin and Cerebral Pseudosclerosis

ArticleYear
A kinetic method amenable to automation for ceruloplasmin estimation with inexpensive and stable reagents.
    Clinical biochemistry, 2007, Volume: 40, Issue:8

    Topics: Adult; Ceruloplasmin; Clinical Chemistry Tests; Dithiothreitol; Female; Ferrozine; Hepatolenticular

2007